Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research

Neurofibromatosis Therapeutic Acceleration Program (NTAP) has created the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research, a program designed to build a community of exceptional clinician scientists who will lead neurofibromatosis type 1 (NF1) research and clinical care. Collins Scholars will receive essential support and resources that will enable them to focus their efforts on improving treatment options for NF1 patients.

The program will support clinician scientists in their last stages of post-doctoral training or in their first seven (7) years of faculty appointment, providing them with funding and resources that include:

  • Full salary support
  • Training in the care of NF1 patients
  • Tuition support and formal training in clinical translational science
  • Participation in collaborative translational research programs with government, academic and industry partners
  • Stipends for research costs
  • Travel costs for scientific meetings
  • High level mentoring support

Eligibility requirements for applicants include the following:

  • Hold a health-professional degree that permits patient care.
  • Commit a minimum of 75% and up to 100% of professional effort to the program for a minimum of two years and a maximum of three years.
  • Be in the last stages of post-doctoral training or a junior faculty member within seven years of the first faculty appointment.
  • Have a commitment to patient focused research in the field of neurofibromatosis type 1 (NF1). A redirection in focus from non-NF1 research to NF1-focused research is welcomed, but must be explained by the candidate and mentors.
  • Demonstrate prior research commitment and accomplishments.
  • Have a mentorship team that includes research, clinical and career mentorship (these roles can be filled by up to three people) with commitment to the candidate‚Äôs training, expertise in the research skill set proposed in the application and in the clinical management of NF1.
  • Agree to meet all of the requirements of the Francis S. ¬†Collins Scholars (FCS) Program in Neurofibromatosis Clinical and Translational Research, including participation in all required Collins Scholars meetings and activities.

The program was launched in 2014, with first applications accepted in February, 2014 and successful recipients being announced in June, 2014. Additional scholarship application rounds will be announced each year. For further information about the program, please see Collins Scholar Application Guidelines and Instructions

About Francis S. Collins

The Scholars Program is named in honor of Dr. Francis S. Collins, who led the team that discovered the NF1 gene in 1990. In addition to this work, Dr. Collins has been at the forefront of advancing translational science in his roles as Director of the National Institutes of Health (NIH) and former Director of the National Human Genome Research Institute. His leadership helped to establish the National Center for Advancing Translational Sciences (NCATS) and Brain Research through Advancing Innovative Neurotechnologies (BRAIN).